John D Shulman - Net Worth and Insider Trading
John D Shulman Net Worth
The estimated net worth of John D Shulman is at least $200,137 dollars as of 2024-12-28. John D Shulman is the Director, 10% Owner of Petros Pharmaceuticals Inc and owns about 570,354 shares of Petros Pharmaceuticals Inc (PTPI) stock worth over $200,137. Details can be seen in John D Shulman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John D Shulman has not made any transactions after 2021-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John D Shulman
John D Shulman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John D Shulman owns 1 companies in total, including Petros Pharmaceuticals Inc (PTPI) .
Click here to see the complete history of John D Shulman’s form 4 insider trades.
Insider Ownership Summary of John D Shulman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PTPI | Petros Pharmaceuticals Inc | 2021-12-22 | director & 10 percent owner |
John D Shulman Latest Holdings Summary
John D Shulman currently owns a total of 1 stock. John D Shulman owns 570,354 shares of Petros Pharmaceuticals Inc (PTPI) as of December 22, 2021, with a value of $200,137.
Latest Holdings of John D Shulman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PTPI | Petros Pharmaceuticals Inc | 2021-12-22 | 570,354 | 0.35 | 200,137 |
Holding Weightings of John D Shulman
John D Shulman Form 4 Trading Tracker
According to the SEC Form 4 filings, John D Shulman has made a total of 3 transactions in Petros Pharmaceuticals Inc (PTPI) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Petros Pharmaceuticals Inc is the acquisition of 14,577 shares on December 22, 2021, which cost John D Shulman around $500,001.
Insider Trading History of John D Shulman
- 1
John D Shulman Trading Performance
GuruFocus tracks the stock performance after each of John D Shulman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John D Shulman is -28.69%. GuruFocus also compares John D Shulman's trading performance to market benchmark return within the same time period. The performance of stocks bought by John D Shulman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John D Shulman's insider trading performs compared to the benchmark.
Performance of John D Shulman
John D Shulman Ownership Network
John D Shulman Owned Company Details
What does Petros Pharmaceuticals Inc do?
Who are the key executives at Petros Pharmaceuticals Inc?
John D Shulman is the director & 10 percent owner of Petros Pharmaceuticals Inc. Other key executives at Petros Pharmaceuticals Inc include 10 percent owner Jcp Iii Sm Aiv, L.p. , 10 percent owner Juggernaut Partners Iii Gp, L.p. , and 10 percent owner Juggernaut Partners Iii Gp, Ltd. .
Petros Pharmaceuticals Inc (PTPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Petros Pharmaceuticals Inc (PTPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Petros Pharmaceuticals Inc (PTPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Petros Pharmaceuticals Inc (PTPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Petros Pharmaceuticals Inc Insider Transactions
John D Shulman Mailing Address
Above is the net worth, insider trading, and ownership report for John D Shulman. Currently GuruFocus does not have mailing address information for John D Shulman.